Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-related Wet Macular Degeneration”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00503022
What this trial is testing

Safety and Tolerability of an Intravenous Infusion of ACZ885 in Patients With Wet Age-Related Macular Degeneration

Who this might be right for
Wet Age-Related Macular Degeneration
Novartis 20
Early research (Phase 1)UnknownNCT03675880
What this trial is testing

TAB014(Drug Code) in Wet( Neovascular)Age-related Macular Degeneration(AMD) Subjects

Who this might be right for
AMD
Lee's Pharmaceutical Limited 24
Testing effectiveness (Phase 2)Study completedNCT03066258
What this trial is testing

Safety and Tolerability of RGX-314 (Investigational Product) Gene Therapy for Neovascular AMD Trial

Who this might be right for
Neovascular Age-related Macular DegenerationWet Age-related Macular Degeneration
REGENXBIO Inc. 42
Post-approval studies (Phase 4)UnknownNCT00813891
What this trial is testing

Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration

Who this might be right for
Macular DegenerationVisual Acuity
McGill University Health Centre/Research Institute of the McGill University Health Centre 180
Testing effectiveness (Phase 2)Study completedNCT03927690
What this trial is testing

Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Novartis Pharmaceuticals 91
Post-approval studies (Phase 4)Study completedNCT02441816
What this trial is testing

VITAL - Individualising Therapy for Neovascular AMD With Aflibercept

Who this might be right for
Age Related Macular Degeneration
Moorfields Eye Hospital NHS Foundation Trust 50
Not applicableActive Not RecruitingNCT03102138
What this trial is testing

Retinal Pigment Epithelium Safety Study for Patients in B4711001

Who this might be right for
Age Related Macular Degeneration
Moorfields Eye Hospital NHS Foundation Trust 10
Not applicableStudy completedNCT01269151
What this trial is testing

Ranibizumab Short- and Log-term Effects on Retinal Function in wAMD

Who this might be right for
Age-Related Macular DegenerationRetinal Function
University of Luebeck 20
Testing effectiveness (Phase 2)UnknownNCT06183814
What this trial is testing

EXG102-031 in Participants With wAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Guangzhou Jiayin Biotech Ltd 42
Not applicableStudy completedNCT07744984
What this trial is testing

The Efficacy of Home OCT Supported Management in Patients Diagnosed With Neovascular-AMD and Undergoing a Drug Switch to Faricimab

Who this might be right for
Age-Related Macular Degeneration (AMD)Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
Rabin Medical Center 12
Not applicableLooking for participantsNCT06893965
What this trial is testing

Acute Intra Ocular Pressure Monitoring After Aflibercept 8mg/0.07mL

Who this might be right for
Macular Diseases
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 100
Early research (Phase 1)WithdrawnNCT02450981
What this trial is testing

Evaluation the Pharmacokinetics, Safety, Tolerability of BCD-021 in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Biocad
Large-scale testing (Phase 3)Study completedNCT00090623
What this trial is testing

RhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Genentech, Inc. 180
Testing effectiveness (Phase 2)Study completedNCT00259753
What this trial is testing

Safety and Efficacy Study of Small Interfering Ribonucleic Acid (RNA) Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
OPKO Health, Inc. 120
Large-scale testing (Phase 3)UnknownNCT04113538
What this trial is testing

Treat and Extend Analysis Trial With Aflibercept in Wet-AMD

Who this might be right for
Wet Age-related Macular Degeneration
Michel Giunta 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06550011
What this trial is testing

Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravitreal (IVT) Injection of ABI-110 (AAV2.N54-VEGF Trap) in Subjects With Neovascular (Wet) Age-Related Macular Degeneration (wAMD), Including Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Neovascular (Wet) AMD
Avirmax Biopharma Inc 18
Early research (Phase 1)Study completedNCT02461771
What this trial is testing

Assessment of Safety, Tolerability and Pharmacokinetics of Intravitreal Pegcetacoplan (APL-2) for Patients With Wet AMD

Who this might be right for
Neovascular Age-Related Macular Degeneration
Apellis Pharmaceuticals, Inc. 13
Large-scale testing (Phase 3)Study completedNCT04740671
What this trial is testing

Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

Who this might be right for
Age Related Macular Degeneration
Shanghai Henlius Biotech 410
Testing effectiveness (Phase 2)Study completedNCT01157065
What this trial is testing

Evaluation of AL-78898A in Exudative Age-Related Macular Degeneration

Who this might be right for
Exudative Age-Related Macular Degeneration
Alcon Research 99
Testing effectiveness (Phase 2)Ended earlyNCT02418754
What this trial is testing

Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration
Regeneron Pharmaceuticals 505
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation